Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 ,inter alia, to consider and approve Unaudited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenotech Laboratories has informed BSE that its Board of Directors will meet on Monday, July 28, 2025, to consider and approve the Unaudited Standalone Financial Results for the quarter ended June 30, 2025 (Q1 FY26). The filing is a standard regulatory intimation under SEBI Listing Regulations. The company also reminded that the trading window for insiders remains closed from July 1, 2025 until July 30, 2025, in line with insider trading norms around results declaration.
This is a routine pre-results announcement and does not itself move the stock. Investors should watch for the actual Q1 FY26 numbers when released on or after July 28, 2025, for clues on revenue, profitability, and margin trends.